ADAM9 and CDCP1 were reported to show increased expression in cells with progressive migration ability (CL1-0 < F4 < Bm7brm) from the same original tumor [3]; we found that miR-1 expression was lower in the lung cancer cells with greater migration (Figure 1G). Here, ADAM9 is linked to lung carcinoma.